BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8827561)

  • 21. The Role of Inferior Turbinate Fracture in the Management of Congenital Nasolacrimal Duct Obstruction.
    Rajabi MT; Inanloo B; Salabati M; Rafizadeh M; Tabatabaie SZ; Bayat R; Mahmoudzadeh R
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):269-271. PubMed ID: 30234839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Success rates of nasolacrimal duct probing at time intervals after 1 year of age.
    Robb RM
    Ophthalmology; 1998 Jul; 105(7):1307-9; discussion 1309-10. PubMed ID: 9663238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of probing for congenital nasolacrimal duct obstruction in children older than 13 months of age.
    Maheshwari R
    Indian J Ophthalmol; 2005 Mar; 53(1):49-51. PubMed ID: 15829747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital nasolacrimal duct obstruction: therapeutic management.
    Chiesi C; Guerra R; Longanesi L; Fornaciari M; Morano RP
    J Pediatr Ophthalmol Strabismus; 1999; 36(6):326-30. PubMed ID: 11132664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of congenital nasolacrimal duct obstruction before and after the age of 1 year.
    Zwaan J
    Ophthalmic Surg Lasers; 1997 Nov; 28(11):932-6. PubMed ID: 9387181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case Series of Dacryoendoscopy in Childhood: A Diagnostic and Therapeutic Alternative for Complex Congenital Nasolacrimal Duct Obstruction Even in the First Year of Life.
    Heichel J; Struck HG; Fiorentzis M; Hammer T; Bredehorn-Mayr T
    Adv Ther; 2017 May; 34(5):1221-1232. PubMed ID: 28341931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct endoscopic probing for congenital lacrimal duct obstruction.
    Sasaki H; Takano T; Murakami A
    Clin Exp Ophthalmol; 2013 Nov; 41(8):729-34. PubMed ID: 23566023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
    Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
    J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nasolacrimal duct disorders in children. Part II. Treatment].
    Sielicka D; Mrugacz M; Bakunowicz-Ɓazarczyk A
    Klin Oczna; 2010; 112(10-12):346-9. PubMed ID: 21473089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in congenital nasolacrimal duct obstruction surgical procedures in the United States from 2003 to 2016.
    Muminovic I; Ryu WY; Lambert SR
    J AAPOS; 2021 Dec; 25(6):354-356. PubMed ID: 34600104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital nasolacrimal duct obstruction: irrigation or probing?
    Kim YS; Moon SC; Yoo KW
    Korean J Ophthalmol; 2000 Dec; 14(2):90-6. PubMed ID: 11213741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2012 Dec; 130(12):1525-33. PubMed ID: 23229693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years.
    Une VL; Kulkarni SS; Nandedkar VS
    J Pediatr Ophthalmol Strabismus; 2019 May; 56(3):141-145. PubMed ID: 31116859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review of endoscopic-assisted surgical management for congenital nasolacrimal duct obstruction.
    Trott S; Colgrove N; Westgate P; Bush M; Iverson K
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110448. PubMed ID: 33091808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
    Kashkouli MB; Kassaee A; Tabatabaee Z
    J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasolacrimal Duct Probing for Young Children With Congenital Nasolacrimal Duct Obstructions in China: A 10-Year Systematic Review.
    Xiang Q; Gao X; Chen X; Qi J; Fang J
    J Pediatr Ophthalmol Strabismus; 2019 Nov; 56(6):365-372. PubMed ID: 31743404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incision of Hasner's valve under endoscopic intranasal surgery for the treatment of nasolacrimal duct obstruction in children.
    Keilani C; Keller P; Piaton JM
    J Laryngol Otol; 2020 Jan; 134(1):56-62. PubMed ID: 31918765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate.
    Frick KD; Hariharan L; Repka MX; Chandler D; Melia BM; Beck RW;
    Arch Ophthalmol; 2011 May; 129(5):603-9. PubMed ID: 21555614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.